Lithium-Sparing Alzheimer’s Therapy has Strong Benefit-to-Risk Profile
Courtesy of Alzamend Neuro On the strength of data from its Phase 1 Study of lead compound, AL001, being developed for…
Courtesy of Alzamend Neuro On the strength of data from its Phase 1 Study of lead compound, AL001, being developed for…